Undervalued Stocks Based On Cash Flows

Results

773

Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.

773 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
CAMBI
NOK 21.400%5.9%NOK 3.4bNOK 28.0025.039.7%1.4%Capital Goods
NORB B
SEK 11.350%-4.2%SEK 649.6mSEK 12.5023.545.8%0%Capital Goods
LIVE
UK£0.791.7%13.6%UK£309.7mUK£0.890.848.3%7.1%Real Estate
HIMS
US$30.825.1%-44.5%US$7.1bUS$29.233.068.5%n/aHealthcare
CVLT
US$124.934.1%-31.8%US$5.2bUS$161.1575.826.6%n/aSoftware
NTRA
US$270.367.2%92.9%US$38.7bUS$282.8615.559.4%n/aPharmaceuticals & Biotech
GREENPANEL
₹196.722.5%-28.1%₹24.1b₹245.561.672.9%0.3%Materials
301338
CN¥84.75-2.6%101.5%CN¥11.5bn/a57.834.4%0.4%Capital Goods
COA
UK£0.81-3.8%10.1%UK£1.6bUK£1.1918.316.9%3.0%Consumer Durables
CMTL
€1.86-1.6%2.8%€34.3m€3.078.918.2%n/aSoftware
BGL
AU$1.30-3.3%52.0%AU$1.9bAU$1.714.439.3%n/aMaterials
OMDA
US$20.510.4%18.3%US$1.2bUS$25.004.3103.3%n/aHealthcare
MODU
€1.05-0.5%-14.5%€44.6m€1.604.368.2%n/aHealthcare
DBAN
€21.451.9%-11.7%€369.8m€34.537.454.5%4.7%Diversified Financials
1801
HK$86.00-3.7%-7.4%HK$149.7bHK$117.76158.532.4%n/aPharmaceuticals & Biotech
300765
CN¥37.36-4.0%-27.5%CN¥50.6bCN¥49.1322.150.8%0.05%Pharmaceuticals & Biotech
CDG
€3.020.7%136.9%€28.2m€3.1745.637.4%1.1%Media
XRO
AU$73.809.0%-58.2%AU$12.2bAU$127.2490.030.1%n/aSoftware
2310
ر.س13.24-2.6%-26.2%ر.س9.6bر.س16.721.9104.2%7.6%Materials
2259
HK$117.00-1.3%n/aHK$310.5bHK$200.1717.818.2%1.3%Materials
A482630
₩12,890.0019.9%45.2%₩264.8b₩29,000.0016.831.7%n/aSemiconductors
DXRX
UK£1.4615.4%6.2%UK£123.6mUK£2.131274.487.0%n/aPharmaceuticals & Biotech
6185
HK$23.14-1.1%-47.8%HK$9.8bHK$50.454.457.2%0%Pharmaceuticals & Biotech
KIST
UK£2.682.9%56.9%UK£222.3mUK£4.071.417.0%n/aEnergy
Page 1 of 22